RGEN
Price:
$146.95
Market Cap:
$8.23B
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test k...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
1986-04-29
Stock Exchange
NASDAQ
Ticker
RGEN
According to Repligen Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -4898.33. This represents a change of 1.17% compared to the average of -386.88 of the last 4 quarters.
The mean historical PE Ratio of Repligen Corporation over the last ten years is 123.66. The current -4898.33 PE Ratio has changed -396196.83% with respect to the historical average. Over the past ten years (40 quarters), RGEN's PE Ratio was at its highest in in the March 2024 quarter at 1.22K. The PE Ratio was at its lowest in in the September 2024 quarter at -3186.49.
Average
123.66
Median
106.56
Minimum
48.92
Maximum
240.96
Discovering the peaks and valleys of Repligen Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 377.20%
Maximum Annual PE Ratio = 240.96
Minimum Annual Increase = -55.54%
Minimum Annual PE Ratio = 48.92
Year | PE Ratio | Change |
---|---|---|
2023 | 240.96 | 377.20% |
2022 | 50.49 | -55.54% |
2021 | 113.57 | -32.42% |
2020 | 168.06 | -19.53% |
2019 | 208.85 | 50.35% |
2018 | 138.91 | 183.93% |
2017 | 48.92 | -44.77% |
2016 | 88.58 | -11.01% |
2015 | 99.54 | 26.39% |
2014 | 78.76 | 193.43% |
The current PE Ratio of Repligen Corporation (RGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
135.01
5-year avg
156.39
10-year avg
123.66
Repligen Corporation’s PE Ratio is less than Intuitive Surgical, Inc. (85.18), less than ResMed Inc. (30.59), less than Merit Medical Systems, Inc. (47.58), less than ICU Medical, Inc. (-34.54), less than The Cooper Companies, Inc. (47.58), less than West Pharmaceutical Services, Inc. (48.29), less than Becton, Dickinson and Company (38.08), less than Hologic, Inc. (21.52), less than Teleflex Incorporated (34.81), less than Haemonetics Corporation (31.82), less than AngioDynamics, Inc. (-1.45), less than AptarGroup, Inc. (31.52), less than Envista Holdings Corp (-2.44),
Company | PE Ratio | Market cap |
---|---|---|
85.18 | $191.28B | |
30.59 | $34.03B | |
47.58 | $5.72B | |
-34.54 | $3.84B | |
47.58 | $18.52B | |
48.29 | $24.00B | |
38.08 | $65.82B | |
21.52 | $16.49B | |
34.81 | $8.21B | |
31.82 | $3.89B | |
-1.45 | $353.11M | |
31.52 | $10.60B | |
-2.44 | $3.26B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Repligen Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Repligen Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Repligen Corporation's PE Ratio?
How is the PE Ratio calculated for Repligen Corporation (RGEN)?
What is the highest PE Ratio for Repligen Corporation (RGEN)?
What is the 3-year average PE Ratio for Repligen Corporation (RGEN)?
What is the 5-year average PE Ratio for Repligen Corporation (RGEN)?
How does the current PE Ratio for Repligen Corporation (RGEN) compare to its historical average?